Medicines and devices listed in the NLEM must be sold at the prices set by National Pharmaceuticals Pricing Authority (NPPA), while those in the non scheduled list are allowed a maximum annual price increase of 10%. The revision of the NLEM aims to ensure that antibiotics are available when needed, and that the right antibiotics are prescribed for the right infections.
